Go Pro

Allstate (NYSE:ALL) Price Target Raised to $292.00 at JPMorgan Chase & Co.

Allstate logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • JPMorgan raised Allstate’s price target to $292 from $282 and maintained an “overweight” rating, implying 10.56% upside from the prior close.
  • Analyst sentiment is mixed: Allstate has an average “Hold” rating and a consensus price target of $263.42, despite several recent target increases.
  • Allstate’s latest quarterly results exceeded expectations, with EPS of $8.99 versus the $6.06 consensus estimate and revenue up 11.8% year over year; shares nevertheless fell 2.1% to $264.11 in Tuesday trading.
  • Interested in Allstate? Here are five stocks we like better.

Allstate (NYSE:ALL - Get Free Report) had its target price boosted by equities research analysts at JPMorgan Chase & Co. from $282.00 to $292.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has an "overweight" rating on the insurance provider's stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 10.56% from the stock's previous close.

Several other brokerages have also commented on ALL. Mizuho raised their price objective on shares of Allstate from $255.00 to $272.00 and gave the stock an "outperform" rating in a report on Thursday, July 9th. Evercore set a $240.00 target price on Allstate in a report on Friday, July 10th. Raymond James Financial reissued a "strong-buy" rating on shares of Allstate in a research report on Tuesday. Morgan Stanley raised their target price on Allstate from $215.00 to $240.00 and gave the company an "equal weight" rating in a research note on Monday, July 6th. Finally, Citigroup cut Allstate from a "neutral" rating to a "sell" rating and set a $240.00 price target on the stock. in a research note on Tuesday. Three analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat, Allstate has an average rating of "Hold" and an average price target of $263.42.

Get Our Latest Report on Allstate

Allstate Trading Down 2.1%

Shares of Allstate stock traded down $5.56 during midday trading on Tuesday, reaching $264.11. 212,044 shares of the company's stock traded hands, compared to its average volume of 1,669,351. The stock has a 50 day moving average of $242.76 and a 200-day moving average of $221.18. Allstate has a 12 month low of $188.08 and a 12 month high of $277.22. The company has a market cap of $67.99 billion, a PE ratio of 5.29, a price-to-earnings-growth ratio of 0.45 and a beta of 0.16. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.36 and a current ratio of 0.36.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, topping the consensus estimate of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The business had revenue of $15.43 billion during the quarter, compared to analyst estimates of $15.46 billion. During the same period in the prior year, the business earned $5.94 EPS. The company's revenue for the quarter was up 11.8% on a year-over-year basis. As a group, equities analysts expect that Allstate will post 31.4 EPS for the current fiscal year.

Insider Activity

In other news, Director Andrea Redmond sold 2,225 shares of the stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $202.91, for a total transaction of $451,474.75. Following the sale, the director owned 2,225 shares in the company, valued at $451,474.75. This represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Mark Q. Prindiville sold 1,550 shares of the firm's stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $216.27, for a total transaction of $335,218.50. Following the sale, the insider directly owned 27,558 shares of the company's stock, valued at $5,959,968.66. This trade represents a 5.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.55% of the stock is owned by insiders.

Institutional Investors Weigh In On Allstate

A number of hedge funds have recently added to or reduced their stakes in the stock. Brighton Jones LLC increased its position in Allstate by 60.2% during the fourth quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider's stock valued at $1,253,000 after acquiring an additional 2,443 shares during the last quarter. Revolve Wealth Partners LLC bought a new stake in shares of Allstate during the 4th quarter valued at about $231,000. WINTON GROUP Ltd bought a new stake in shares of Allstate during the 2nd quarter valued at about $210,000. Treasurer of the State of North Carolina increased its position in shares of Allstate by 2.5% during the 2nd quarter. Treasurer of the State of North Carolina now owns 123,272 shares of the insurance provider's stock valued at $24,816,000 after purchasing an additional 3,051 shares during the last quarter. Finally, Ieq Capital LLC lifted its stake in shares of Allstate by 20.1% in the 2nd quarter. Ieq Capital LLC now owns 38,316 shares of the insurance provider's stock worth $7,713,000 after purchasing an additional 6,412 shares during the period. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

About Allstate

(Get Free Report)

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.

Further Reading

Analyst Recommendations for Allstate (NYSE:ALL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines